Semaglutide FDA approval was first granted on December 5, 2017, for the brand Ozempic
Semaglutide drug is used for weight loss and is sometimes combined with vitamin B12 to improve results and energy levels
This treatment is a valuable tool for those struggling with excess weight or obesity, especially when other methods haven't yielded the desired results
Even light movement like brisk walking can help get things going
Compounded options, international sources, or alternative medications might provide similar benefits at lower cost
Renal and neuroprotection research: Studied for kidney-protective effects in diabetic nephropathy, as well as therapeutic potential in Alzheimers disease, Parkinsons disease, and cognitive decline